Advertisement Quick-Med and Foster sign joint development agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Quick-Med and Foster sign joint development agreement

Quick-Med Technologies, a life sciences company, has entered into a joint development agreement with Foster, a member of PolyMedex Discovery Group, to collaborate in applying Quick-Med's Nimbus technology to thermoplastics for catheters and other medical product applications.

According to Quick-Med, the Nimbus is a next-generation wound care technology that is non-toxic, long-lasting and not blocked by organics such as blood, urine and perspiration.

Ladd Greeno, CEO of Quick-Med, said: “We are excited to team with Foster to incorporate our Nimbus technology in catheters. Foster is a respected leader developing advanced biomedical materials to meet the requirements of medical device manufacturers. This collaboration will leverage Nimbus technology to a next generation of antimicrobial catheters to address growing infection concerns.”